23andme + Genetic Testing = Consumer Engagement

by Bradley Miller on May 11, 2010

{ 2 comments… read them below or add one }

TomPeddicord May 12, 2010 at 10:51 am

With yesterday’s announcement that Walgreens is offering the The Insight kit from Pathway Genomics for around $250, your blog couldn’t have been more timely… Your thoughts above are similar to those discussed in the Decision Tree (http://thedecisiontree.com/blog/) in patients are able to collect so many more data points and our ability to correlate these with outcomes will potentially change how we monitor drug safety and other disease outcomes over time with these increased data points.

Thanks, enjoyed your blog…if you follow me on twitter, we can continue the sharing of information….Cheers!

Bradley Miller May 12, 2010 at 9:59 pm

The Insight Genomics announcement was a nice coincidence, indeed! The one thing I’d say toTom’s comment is that correlating gene data to outcome data will be important – but that will require even more work and stickyness on 23andme’s part. However, collecting phenotypic data along with the genomic data – that will allow for pretty powerful science as well in the future.

Leave a Comment

Previous post:

Next post: